{"id":25631,"date":"2017-11-15T20:26:47","date_gmt":"2017-11-16T01:26:47","guid":{"rendered":"https:\/\/digital.hbs.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/"},"modified":"2017-11-15T20:26:47","modified_gmt":"2017-11-16T01:26:47","slug":"the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals","status":"publish","type":"hck-submission","link":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/","title":{"rendered":"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals"},"content":{"rendered":"

The pharmaceutical industry has long been troubled by the alarmingly high rate of counterfeit medicines entering the global supply chain. The World Health Organization defines counterfeit medicines as products fraudulently produced or mislabeled to give the appearance of being genuine [1]. These fraudulent medicines can be detrimental, and even lethal, to patient health as they may contain inconsistent levels of the active pharmaceutical ingredient, or may be manufactured in unregulated and unsafe conditions [2]. In addition to patient impact, counterfeit products directly influence pharmaceutical company revenues and reputations, as these products cannibalize genuine product markets and weaken brand image and credibility. With a 56% increase in international counterfeit pharmaceutical incidents between 2012 and 2016 (Figure 1), this is a growing problem that is amplified in complex global supply chains for large pharmaceutical companies. One such company that has recently felt the pain is Genentech, which was the victim of 3 counterfeit incidents of its blockbuster cancer drug Avastin beginning in 2012 within the United States (Figure 2) [3, 4].<\/p>\n

 <\/p>\n

\"\"<\/a>
Figure 1:<\/strong> Total number of fraudulent pharmaceutical incidents has risen by 56% since 2012. A fraudulent incident is defined as either counterfeiting, illegal diversion or theft [2].<\/figcaption><\/figure><\/blockquote>\n

How can pharmaceutical companies such as Genentech address counterfeiting? <\/strong><\/p>\n

One potential answer lies in leveraging the rise of digitalization to better trace all products and their constituent parts across the global supply chain. Genentech has taken this initial step by partnering with other large pharmaceutical companies to invest in the MediLedger Project [5]. This project leverages blockchain technology to create a dependable record of all transactions within Genentech\u2019s complex pharmaceutical supply chain. The project aims to integrate the recording of drug deliveries for all stakeholders in the supply chain in one computer system. As a result, each step in the distribution process will be recorded digitally, creating a permanent record of when the drug is exchanged between stakeholders. Thus, in addition to making it more difficult for criminals to introduce fraudulent materials or steal pharmaceuticals from the supply chain, this would allow for increased speed in tracing and investigating when disruptions occur. By successfully completing a pilot and investing heavily in leveraging blockchain technology, Genentech is riding the digitalization wave to get a firmer grip on its global supply chain over the next 3-10 years. However, this is not enough.<\/p>\n

\"\"<\/a>
Figure 2:<\/strong> In 2012, there were multiple discovered cases of counterfeit Avastin being distributed in the United States. This image illustrates the difference between the original (top) and it\u2019s fraudulent counterpart (bottom) [4].<\/figcaption><\/figure><\/blockquote>\n

What are the risks? What else can Genentech do?<\/strong><\/p>\n

Genentech must remain cautious about overreliance on digitalization. The downside of new technologies, such as blockchain, is the ever-present threat to cyber security [6]. As we have seen recently, cyber attacks can be detrimental to customers as well as company profits and credibility. In an industry where mistakes could directly lead to adverse patient outcomes, the stakes are even higher, and thus safeguards must be put in place when connecting an entire global supply chain using blockchain. As each stakeholder, whether it be the drug maker, distributor or hospital, owns a particular node in the blockchain, a cyber attack that impacts any one of these nodes, could lead to mismanagement of drugs along the supply chain.<\/p>\n

Thus, Genentech must invest in non-digital mechanisms for dealing with counterfeiting. One such way is to innovate packaging and labeling techniques to make it impossible to replicate. This would include investing in R&D to further complicate barcodes and create additional unique identifiers for each drug. Further, Genentech should invest in authentication procedures that allow stakeholders within the supply chain, and especially hospitals, to more rapidly confirm the validity of drugs when they are received. Finally, Genentech should continue investing in mass serialization internationally to work toward improved traceability on the global scale.<\/p>\n

Remaining Questions<\/strong><\/p>\n

While blockchain technology and the rise of digitalization provide exciting potential solutions, the challenges of securing a complex global supply chain in the pharmaceutical industry are plenty, and many questions remain. This new approach relies on participation by all parties in the supply chain, but will all stakeholders be open to adopting this new technology? Even if they are open to it, will they have the infrastructure and means to do so? Further, will switching to blockchain introduce more problems (in the form of cyber security) than it will help solve? In any case, the rise of digitalization has given corporations like Genentech new ways to address problems that have plagued the industry for decades.<\/p>\n

(Word Count: 757)<\/p>\n

 <\/p>\n

References<\/p>\n

[1] \u201cSubstandard, Spurious, Falsely Labelled, Falsified and Counterfeit (SSFFC) Medical Products.\u201d World Health Organization, 1 Jan. 2016, www.who.int\/mediacentre\/factsheets\/fs275\/en\/.<\/p>\n

[2] \u201cCounterfeit Situation.\u201d Pharmaceutical Security Institute, 2017, www.psi-inc.org\/counterfeitSituation.cfm.<\/p>\n

[3] Blackstone, Erwin A., et al. \u201cThe Health and Economic Effects of Counterfeit Drugs.\u201d American Health & Drug Benefits, June 2014, ncbi.nlm.nih.gov\/pmc\/articles\/PMC4105729\/.<\/p>\n

[4] \u201cGenentech Warns of Fake Avastin.\u201d 15 Feb. 2012, www.in-pharmatechnologist.com\/Article\/2012\/02\/15\/Genentech-warns-of-fake-Avastin.<\/p>\n

[5] Roberts, Jeff John.\u00a0\u201cBig Pharma Turns to Blockchain to Track Meds.\u201d Fortune, 21 Sept. 2017, fortune.com\/2017\/09\/21\/pharma-blockchain\/.<\/p>\n

[6] Berke, Allison. \u201cHow Safe Are Blockchains? It Depends.\u201d\u00a0性视界 Business Review, 7 Mar. 2017, hbr.org\/2017\/03\/how-safe-are-blockchains-it-depends.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Pharmaceutical industry has been plagued by the realities of counterfeit medicines being introduced into their complex supply chains for decades. With increasing threats to patient lives and brand credibility, companies are looking for innovative solutions. The rise of digitalization, and specifically blockchain technology, gives new hope for solving Big Pharma’s global supply chain issue.<\/p>\n","protected":false},"author":9979,"featured_media":25632,"comment_status":"open","ping_status":"closed","template":"","categories":[2608,3439,2123],"class_list":["post-25631","hck-submission","type-hck-submission","status-publish","has-post-thumbnail","hentry","category-blockchain","category-counterfeit-drugs","category-digitalization","hck-taxonomy-organization-genentech","hck-taxonomy-industry-pharmaceutical","hck-taxonomy-country-united-states"],"connected_submission_link":"https:\/\/d3.harvard.edu\/platform-rctom\/assignment\/rc-tom-challenge-2017\/","yoast_head":"\nThe Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals - Technology and Operations Management<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals - Technology and Operations Management\" \/>\n<meta property=\"og:description\" content=\"The Pharmaceutical industry has been plagued by the realities of counterfeit medicines being introduced into their complex supply chains for decades. With increasing threats to patient lives and brand credibility, companies are looking for innovative solutions. The rise of digitalization, and specifically blockchain technology, gives new hope for solving Big Pharma's global supply chain issue.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Technology and Operations Management\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2017\/11\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2500\" \/>\n\t<meta property=\"og:image:height\" content=\"1250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/\",\"name\":\"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals - Technology and Operations Management\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2017\\\/11\\\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg\",\"datePublished\":\"2017-11-16T01:26:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2017\\\/11\\\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg\",\"contentUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2017\\\/11\\\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg\",\"width\":2500,\"height\":1250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Submissions\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/#website\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/\",\"name\":\"Technology and Operations Management\",\"description\":\"MBA Student Perspectives\",\"potentialAction\":[{\"@type\":\"性视界Action\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals - Technology and Operations Management","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals - Technology and Operations Management","og_description":"The Pharmaceutical industry has been plagued by the realities of counterfeit medicines being introduced into their complex supply chains for decades. With increasing threats to patient lives and brand credibility, companies are looking for innovative solutions. The rise of digitalization, and specifically blockchain technology, gives new hope for solving Big Pharma's global supply chain issue.","og_url":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/","og_site_name":"Technology and Operations Management","og_image":[{"width":2500,"height":1250,"url":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2017\/11\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/","url":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/","name":"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals - Technology and Operations Management","isPartOf":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2017\/11\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg","datePublished":"2017-11-16T01:26:47+00:00","breadcrumb":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/#primaryimage","url":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2017\/11\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg","contentUrl":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2017\/11\/New-frontier-for-pharmaceuticals-interview_Montigny.jpg","width":2500,"height":1250},{"@type":"BreadcrumbList","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/the-illegal-drug-trade-leveraging-digitalization-and-blockchain-to-prevent-counterfeiting-of-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3.harvard.edu\/platform-rctom\/"},{"@type":"ListItem","position":2,"name":"Submissions","item":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/"},{"@type":"ListItem","position":3,"name":"The Illegal Drug Trade: Leveraging Digitalization and Blockchain to Prevent Counterfeiting of Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/#website","url":"https:\/\/d3.harvard.edu\/platform-rctom\/","name":"Technology and Operations Management","description":"MBA Student Perspectives","potentialAction":[{"@type":"性视界Action","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3.harvard.edu\/platform-rctom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/hck-submission\/25631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/hck-submission"}],"about":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/types\/hck-submission"}],"author":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/users\/9979"}],"replies":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/comments?post=25631"}],"version-history":[{"count":0,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/hck-submission\/25631\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/media\/25632"}],"wp:attachment":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/media?parent=25631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/categories?post=25631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}